Increased Plasma Thrombin-Activatable Fibrinolysis Inhibitor Levels in Normotensive Type 2 Diabetic Patients with Microalbuminuria-Reference-Cited by-同舟云学术

Increased Plasma Thrombin-Activatable Fibrinolysis Inhibitor Levels in Normotensive Type 2 Diabetic Patients with Microalbuminuria

Published:2003-02-01 Issue:2 Volume:88 Page:736-741
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Yano Yutaka¹,Kitagawa Nagako¹,Gabazza Esteban C.¹,Morioka Kohei¹,Urakawa Hideki¹,Tanaka Takashi¹,Katsuki Akira¹,Araki-Sasaki Rika¹,Hori Yasuko¹,Nakatani Kaname²,Taguchi Osamu¹,Sumida Yasuhiro¹,Adachi Yukihiko¹

Affiliation:

1. Third Department of Internal Medicine (Y.Y., N.K., E.C.G., K.M., H.U., T.T., A.K., R.A.-S., Y.H., O.T., Y.S., Y.A.), Mie 514-8507, Japan

2. Department of Laboratory Medicine (K.N.), Mie University School of Medicine, Tsu, Mie 514-8507, Japan

Publisher

The Endocrine Society

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/88/2/736/9149339/jcem0736.pdf

Reference36 articles.

1. Haemostatic variables associated with diabetes and its complications.;Fuller;Br Med J,1979

2. Diabetes, fibrinogen and risk of cardiovascular disease: the Framingham experience.;Kannel;Am Heart J,1990

3. Fifteen coagulation and fibrinolysis parameters in diabetes mellitus and in patients with vasculopathy.;Christe;Thromb Haemost,1984

4. Protein C activation in NIDDM patients.;Gabazza;Diabetologia,1996

5. Changes in fibrinolytic parameters in male patients with type 2 (non-insulin-dependent) diabetes mellitus.;Takada;Thromb Res,1993

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma thrombin-activatable fibrinolysis inhibitor and the 1040C/T polymorphism are risk factors for diabetic kidney disease in Chinese patients with type 2 diabetes;PeerJ;2023-11-14

2. Carboxypeptidase U (CPU, TAFIa, CPB2) in Thromboembolic Disease: What Do We Know Three Decades after Its Discovery?;International Journal of Molecular Sciences;2021-01-17

3. Lipopolysaccharide-binding protein (LBP) reverses the amyloid state of fibrin seen in plasma of type 2 diabetics with cardiovascular co-morbidities;Scientific Reports;2017-08-29

4. Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk;Cardiovascular Diabetology;2017-03-09

5. Mechanisms of Hypercoagulation and Aberrant Clot Lyses in Type 2 Diabetes;Mechanisms of Vascular Defects in Diabetes Mellitus;2017